Stock Analysts upgrades for Monday, August 17th: Avalanche Biotechnologies (NASDAQ:AAVL) was upgraded by analysts at Chardan Capital from a neutral rating to a buy rating. Chardan Capital currently has $17.50 price target on the stock. The ... SleekMoney, 1 month ago
A policeman accused of extortion by a famous likay singing family has hit back with a defamation complaint. Pachapon Rodpothong laid a counter-complaint with the Crime Suppression Division last week, days after a visit by Mit Mitchai, younger ...Bangkok Post, 1 day ago
on your WebpageAdd Widget >Get your members hooked!